The production of radiopharmaceuticals ascompared to traditional pharmaceuticals is a multifaceted procedure andrequires specialized facilities, equipment and operational expertise. Further,owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatorymarket authorization process. Consequently, a number of innovator companieshave demonstrated a preference for outsourcing radiopharmaceuticalmanufacturing to contract service providers.
To order this 320+page report, which features 45+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
The USD 6+ billion (by 2030)financial opportunity associated with nuclear medicine and radiopharmaceuticalsmanufacturing, has been analyzed across the following segments:
§ Target DiseaseIndication
- Breast Cancer
- Chronic Lymphocytic Leukemia
- Colorectal Cancer
- Head and Neck Cancer
- Lung Cancer
- Lupus Nephritis
- Melanoma
- Multiple Myeloma
- Primary Sjögren's Syndrome
- Others
§ Target ImmuneCheckpoint
- B7-H3
- CD38
- CD40
- CD47
- Others
§ Mechanism of Action
- Inhibitory
- Stimulatory
§ Therapeutic Modality
- Monoclonal Antibody
- Small Molecule
§ Type of Therapy
- Monotherapy
- Combination Therapy
§ Route ofAdministration
- Intravenous
- Subcutaneous
- Others
§ Key GeographicalRegions
- North America
- Europe
- Asia-Pacific and the Rest of the World
The NuclearMedicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features thefollowing companies, which we identified to be key players in this domain:
§ Advanced AcceleratorApplications
§ Belgian NuclearResearch Center (SCK•CEN)
§ Cardinal Health
§ China Isotope &Radiation Corporation
§ Curium Pharma
§ DuChemBio
§ Eckert & Ziegler
§ Eczacibasi-Monrol
§ GE Healthcare
§ Jubilant DraxImage
§ Lantheus MedicalImaging
§ Nihon Medi-Physics
§ Nordion
§ PETNET Solutions
§ SinoTauPharmaceuticals
§ SOFIE
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine andRadiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine and RadiopharmaceuticalsManufacturers (Non-Industry Players): Current Market Landscape
6. Nuclear Medicine and RadiopharmaceuticalsManufacturers in North America
7. Nuclear Medicine and RadiopharmaceuticalsManufacturers in Europe
8. Nuclear Medicine and RadiopharmaceuticalsManufacturers in Asia-Pacific And Rest of The World
9. Nuclear Medicine andRadiopharmaceuticals Manufacturers: Company Competitiveness Analysis
10. Partnerships and Collaborations
11. Production and Supply Chain of MedicalIsotope Molybdenum-99 (Technetium-99m)
12. Market Forecast and Opportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies andOrganizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
Facebook Conversations